IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

被引:0
|
作者
Reggidori, N. [1 ]
Lani, L. [1 ]
Renzulli, M. [2 ]
Gramenzi, A. [1 ]
Iannone, G. [1 ]
Granito, A. [1 ]
Piscaglia, F. [1 ]
Golfieri, R. [2 ]
Trevisani, F. [1 ]
Biselli, M. [1 ]
机构
[1] Dept Med & Surg Sci, Bologna, Italy
[2] Dept Specialist Diagnost & Sperimental Med, Bologna, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T.08.10
引用
收藏
页码:S151 / S151
页数:1
相关论文
共 50 条
  • [31] Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib
    Takeda, Haruhiko
    Nishikawa, Hiroki
    Iguchi, Eriko
    Ohara, Yoshiaki
    Sakamoto, Azusa
    Hatamaru, Keiichi
    Henmi, Shinichiro
    Saito, Sumio
    Nasu, Akihiro
    Komekado, Hideyuki
    Kita, Ryuichi
    Kimura, Toru
    Osaki, Yukio
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (02) : 241 - 248
  • [32] Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Labenz, Christian
    Prenosil, Vera
    Koch, Sandra
    Huber, Yvonne
    Marquardt, Jens U.
    Schattenberg, Joern M.
    Galle, Peter R.
    Weinmann, Arndt
    Woerns, Marcus-Alexander
    [J]. DIGESTIVE DISEASES, 2017, 36 (01) : 78 - 88
  • [33] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    [J]. MEDICAL SCIENCE MONITOR, 2021, 27
  • [34] Changes of Cytokines in Cirrhosis Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
    Nagai, Hidenari
    Mukozu, Takanori
    Matui, Daigo
    Ogino, Yu
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S979 - S979
  • [35] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [36] Factors Contributing to the Overall Survival in Patients with Hepatocellular Carcinoma Treated by Sorafenib
    Tsukui, Yuya
    Mochizuki, Hitoshi
    Hoshino, Yuji
    Kawakami, Satoshi
    Kuno, Toru
    Fukasawa, Yoshimitsu
    Iwamoto, Fumihiko
    Hirose, Sumio
    Yoshida, Takashi
    Hosoda, Kenji
    Suzuki, Youji
    Hosoda, Kazuhiko
    Kojima, Yuichiro
    Hirose, Yuichi
    Shindou, Kuniaki
    Matsuda, Masanori
    Yagawa, Syoji
    Tawara, Akio
    Kobayashi, Masashi
    Konishi, Toshiyuki
    Yamazaki, Takahisa
    Takahashi, Seiichiro
    Fujii, Hideki
    Enomoto, Nobuyuki
    Omata, Masao
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2536 - 2539
  • [37] Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
    Williet, Nicolas
    Clavel, Lea
    Bourmaud, Aurelie
    Verot, Celine
    Bouarioua, Nadia
    Roblin, Xavier
    Merle, Philippe
    Phelip, Jean-Marc
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1043 - 1049
  • [38] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
    Kim, Hwi Young
    Park, Joong-Won
    Nam, Byung-Ho
    Kim, Hyun Keun
    Choi, Joon-Il
    Kim, Tae Hyun
    Kim, Hyun Beom
    Kim, Chang-Min
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (11) : 1612 - 1618
  • [40] Early alpha-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Lee, Sangheun
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 39 - +